Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
Stopped early · Not applicable
Conditions studied: Bladder Cancer, Hemostasis
In brief
Evaluate the utility/safety of an FDA-approved tissue sealing device during radical cystectomy as compared to an FDA-approved stapling device.
Key facts
- Study ID
- NCT00802633
- Run by
- Vanderbilt University
- People needed
- 80
- Starts
- 2008-11-01
- Expected to finish
- 2012-06-01
- Last updated by the study team
- 2014-02-11
Who can join
Age: 19 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Muscle invasive bladder cancer
- Male/Female gender
Where it is running
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.